OakChart

Electromed Inc

ELMDHealthcare·Medical Devices·USA·Micro·AMEX·Nov 11 • 3:28 PM ET

25.35-1.83 (-6.74%)
2026-11-11 21:29 CET
Market cap
225.24 USD m
Revenue, TTM
75.57 USD m
Net income, TTM
11.93 USD m
Free cash flow, TTM
8.70 USD m
EPS diluted, TTM
1.37
P/E
18.51
Compare

Price

ELMD against its 20, 50 and 200-day averages
2050200beat
30.0040.00293K586KVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ELMDclose 25.3520-day 27.0650-day 27.36200-day 31.2325.3552w high

46.5% under the 52-week high of 47.40 on 7 Jul 2026. 52-week low 23.01 on 25 Feb 2026. Last 15 sessions, 15.4% high to low

Volume 1.04× normal · the line is the 50-bar volume average

Profile

ELMD
52-week range, 10% of the way up
23.0147.40

Electromed, Inc. engages in the development, manufacturing, marketing, and sale of medical equipment. The firm's products include SmartVest SQL System and SmartVest Connect. It focuses on building market awareness, and acceptance of its products and services with physicians, clinicians, patients, and third-party payers. The company was founded by Robert D. Hansen and Craig N. Hansen in 1992 and is headquartered in New Prague, MN.

IndexRUT
Employees197
IPOAug 13, 2010
Beta0.44
ATR, 14d1.13
Rel volume1.04
Short float2.63%
Insider own17.21%
Inst own60.90%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap210.06M
Enterprise Value194.18M
Income11.93M
Sales75.57M
Book/sh6.37
Cash/sh1.92
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees197
IPOAug 13, 2010

Ratios

P/E18.51
Forward P/E15.00
PEG0.87
P/S2.78
P/B3.98
P/C13.23
P/FCF24.14
EV/EBITDA12.31
EV/Sales2.57
Quick Ratio6.66
Current Ratio7.19
Debt/Eq0.00
LT Debt/Eq0.00
Option/ShortYes / Yes

Earnings

EPS (ttm)1.37
EPS next Y1.69
EPS next Q0.39
EPS this Y11.92%
EPS next Y16.15%
EPS next 5Y17.15%
EPS past 3/5Y52.90% 37.46%
Sales past 3/5Y15.35% 15.59%
EPS Y/Y TTM53.24%
Sales Y/Y TTM14.12%
EPS Q/Q28.09%
Sales Q/Q10.63%
EarningsNov 10 AMC
EPS/Sales Surpr.25.49% -0.89%

Ownership

Insider Own17.21%
Insider Trans-4.13%
Inst Own60.90%
Inst Trans-0.14%
ROA20.79%
ROE24.53%
ROIC22.73%
Gross Margin78.98%
Oper. Margin19.45%
Profit Margin15.78%
SMA20-6.32%
SMA50-7.35%
SMA200-18.84%
Trades-

Technical

Shs Outstand8.24M
Shs Float6.86M
Short Float2.63%
Short Ratio2.19
Short Interest0.18M
52W High47.40 -46.52%
52W Low23.01 10.16%
Volatility4.10% 3.26%
ATR (14)1.13
RSI (14)34.95
Beta0.44
Rel Volume1.04
Avg Volume82.45K
Volume79,044

Performance

Perf Week-9.50%
Perf Month-8.43%
Perf Quarter-40.41%
Perf Half Y-25.51%
Perf YTD-12.95%
Perf Year0.95%
Perf 3Y147.29%
Perf 5Y106.08%
Perf 10Y548.28%
Recom1.00
Target Price48.50
Prev Close27.18
Price25.35
Change %-6.74%

Analyst ratings

latest 6 of 6
DateActionAnalystRating changeTargetImplied
Aug 27, 2025ResumedLLake StreetBuy$36+42.0%
Jul 22, 2025InitiatedRRoth CapitalBuy$29+14.4%
Feb 20, 2025InitiatedRB. Riley SecuritiesBuy$38+49.9%
Oct 18, 2019InitiatedDDougherty & CompanyBuy$12-52.7%
Dec 31, 2013ReiteratedFFeltl & Co.Buy$1.80 → $2.75-89.2%
Oct 19, 2010InitiatedFFeltl & Co.Buy$5-80.3%

Peers

Mkt cap
TickerCompanyMkt cap
VMDViemed Healthcare Inc345.59M
INGNInogen Inc148.73M
AHCOAdaptHealth Corp1.06B
BAXBaxter International Inc13.69B
LUNGPulmonx Corp126.12M
INFUInfuSystem Holdings Inc302.40M
PHGKoninklijke Philips NV ADR29.54B
ECORElectroCore Inc72.16M
INSMInsmed Inc26.30B
UTMDUtah Medical Products Inc208.56M

Insider trading

9 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Cunniff James L.CEO and PresidentJun 08 '26Option Exercise17.259,700167,325157,451Jun 09 05:12 PM
Cunniff James L.CEO and PresidentJun 08 '26Sale36.509,700354,095147,751Jun 09 05:12 PM
Nagel Bradley M.Chief Financial OfficerJun 04 '26Option Exercise10.509,601100,83331,439Jun 08 07:39 PM
Nagel Bradley M.Chief Financial OfficerJun 04 '26Sale36.3511,801428,93619,638Jun 08 07:39 PM
Cunniff James L.OfficerJun 08 '26Proposed Sale36.509,700354,095Jun 08 01:19 PM
Nagel Bradley M.OfficerJun 04 '26Proposed Sale36.3511,801428,937Jun 04 03:50 PM
SKARVAN KATHLEENDirectorMay 15 '26Option Exercise3.8240,000152,80075,622May 19 04:44 PM
SKARVAN KATHLEENDirectorMay 15 '26Sale35.4840,0001,419,35835,622May 19 04:44 PM
SKARVAN KATHLEENDirectorMay 15 '26Proposed Sale35.4840,0001,419,358May 15 04:25 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
FSMDFidelity Small-Mid Multifactor ETFAUM: 2.48B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
DFMCU.S. Micro Cap Portfolio ETF Class SharesAUM: 212.10M
IWCiShares Micro-Cap ETFAUM: 1.22B
DFACU.S. Core Equity 2 Portfolio-ETF Class SharesAUM: 49.14B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2027Q12026-11-100.3200.2550.31518.6818.852
2026Q42026-08-250.3900.3170.38919.4219.333
2026Q32026-05-120.3500.2500.34718.5817.603
2026Q22026-02-100.3200.2600.31818.9018.054
2026Q12025-11-120.2500.2050.24616.8916.634
2025Q42025-08-260.2500.2170.25317.3916.643
2025Q32025-05-130.2100.2020.21115.6815.752
2025Q22025-02-110.2200.1800.22016.2615.301
2025Q12024-11-120.1600.0300.16414.6713.501
2024Q42024-08-270.2000.1400.20314.8315.001
2024Q32024-05-070.1700.1300.16813.8713.801
2024Q22024-02-130.1900.1000.19013.6913.301
2024Q12023-11-070.0200.1000.01812.3212.601
2023Q42023-08-220.1200.1300.11813.6112.801
2023Q32023-05-090.1200.0950.12312.0712.052
2023Q22023-02-140.1100.0200.11311.7311.052

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY0.230-0.22931.30-
2020FY0.4310.1800.47232.4731.27
2021FY0.2700.2750.26535.7635.65
2022FY0.2600.3000.26341.6641.00
2023FY0.3600.3700.36448.0747.30
2024FY0.5800.5100.58154.7254.90
2025FY0.8500.8150.84664.0063.18
2026FY1.3001.2171.30073.7873.60
2027FY-1.455--83.15
2028FY-1.690--92.05
2029FY-2.090--102.8
2030FY-1.150--85.80

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2027Q2S2026-11-1120021.2021.2021.20
2027Q2S2026-11-1020021.2021.2021.20
2027Q2S2026-11-0920021.2021.2021.20
2027Q2S2026-08-2620121.2021.2021.20
2027Q2S2026-08-0130021.4321.4021.50
2027Q2S2026-07-2731021.4321.4021.50
2027Q2S2026-05-1832021.4321.4021.50
2027Q2S2026-05-1331021.2721.0021.40
2027Q2S2026-05-0630020.9020.4021.30
2027Q2S2026-04-2740020.9520.4021.30
2027Q2S2026-02-1141020.9520.4021.30
2027Q2S2026-01-2720020.2520.2020.30
2027Q2S2025-11-1321120.2520.2020.30
2027Q2S2025-11-1120020.0019.4020.60

Estimate history

EPS, annual0.2120.2290.4720.2650.2630.3640.5810.8461.3011.3695
Period201820192020202120222023202420252026TTM
EPS, quarterly0.1640.220.2110.2530.2460.3180.3470.3890.315
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
Sales, annual28.30731.332.47135.75641.65948.06754.7166473.77675.57
Period201820192020202120222023202420252026TTM
Sales, quarterly14.66816.25515.68417.39316.88718.89718.57519.41718.682
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
Shares, annual8.2898.4088.5688.5338.4758.5558.6388.3498.3668.237
Period201820192020202120222023202420252026MRQ
Shares, quarterly8.4578.5578.518.3498.3578.288.288.3668.237
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Income statement, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue75.5773.7864.0054.7248.0741.6635.7632.4731.30
Cost of Goods Sold Incl. D&A15.8915.8314.0312.9911.5510.228.457.277.45
Gross Profit59.6857.9449.9741.7336.5231.4427.3025.2023.85
Selling, General and Administrative Excl. Other44.9844.0640.1035.1532.5128.4724.1620.9921.01
Research and Development1.351.311.000.660.921.361.721.050.58
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income14.7013.889.876.584.012.973.144.212.83
Interest Expense0.000.000.000.000.000.000.00--
Unusual Expense0.000.000.210.000.000.000.00-0.910.01
Net Income Before Taxes15.1914.3610.287.044.093.003.175.242.92
Income Taxes3.273.062.751.890.920.690.811.080.94
Consolidated Net Income11.9311.307.545.153.172.312.364.161.98
Net Income From Continuing Operations11.9311.307.545.153.172.312.364.161.98
Net Income11.9311.307.545.153.172.312.364.161.98
EPS (Recurring)1.361.300.860.580.360.260.270.400.23
EPS (Basic, Before Extraordinaries)1.441.370.890.600.370.270.280.500.24
EPS (Diluted)1.371.300.850.580.360.260.270.470.23
EBITDA15.7814.9611.047.424.623.603.754.943.76
Non-Operating Income (Expense)0.490.480.620.460.080.030.030.120.09
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.132.152.421.340.560.770.750.660.67
Price To Earnings Ratio20.9020.9027.5630.4129.4636.7042.6732.6123.48
Price To Sales Ratio3.274.983.062.441.942.032.814.181.50
Gross Margin78.9878.5478.0876.2675.9875.4776.3677.6176.19
Operating Margin19.4518.8215.4312.038.347.138.7812.959.06
Net Margin15.7815.3211.789.416.595.536.6112.826.33
Shares Outstanding8.248.378.358.648.568.488.538.578.41
Market Capitalization225.24225.24184.41130.1091.6982.0797.52130.5745.82

Income statement, quarterly

Currency USD, millions
Metric2027Q12026Q42026Q32026Q22026Q12025Q42025Q32025Q2
Total Revenue18.6819.4218.5718.9016.8917.3915.6816.25
Cost of Goods Sold Incl. D&A3.754.133.934.083.693.773.463.63
Gross Profit14.9415.2814.6414.8213.2013.6212.2312.63
Selling, General and Administrative Excl. Other11.4511.4610.8811.2010.5310.3710.0910.09
Research and Development0.280.330.360.380.240.300.280.25
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income3.493.833.773.622.673.252.142.54
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.210.000.00
Net Income Before Taxes3.643.963.873.732.803.172.282.69
Income Taxes0.880.560.860.970.670.970.390.73
Consolidated Net Income2.763.403.002.762.142.201.891.97
Net Income From Continuing Operations2.763.403.002.762.142.201.891.97
Net Income2.763.403.002.762.142.201.891.97
EPS (Recurring)0.320.390.350.320.250.270.210.22
EPS (Basic, Before Extraordinaries)0.330.410.370.330.260.260.220.23
EPS (Diluted)0.320.390.350.320.250.250.210.22
EBITDA3.754.104.053.882.933.652.422.81
Non-Operating Income (Expense)0.150.140.100.110.130.140.140.15
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.340.600.670.520.360.510.600.75
Price To Earnings Ratio20.9032.5320.1231.3328.9627.5631.6040.74
Price To Sales Ratio3.275.012.823.673.223.003.484.44
Gross Margin79.9578.7178.8378.4278.1578.3377.9777.68
Operating Margin18.6819.7020.2719.1615.8118.7013.6415.64
Net Margin14.7817.5216.1714.6112.6512.6712.0612.11
Shares Outstanding8.248.378.288.288.368.358.518.56
Market Capitalization225.24350.25193.72242.88204.97184.41204.17249.93

Balance sheet, annual

Currency USD, millions
Metric2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments20.4515.2916.087.378.1511.8910.487.817.46
Short Term Receivables32.0726.1024.0524.6221.3417.4314.1113.7612.59
Inventories3.683.303.714.223.182.113.082.622.49
Other Current Assets1.170.390.331.581.870.280.350.350.76
Total Current Assets57.3745.0844.1737.7934.5431.7028.0224.5423.29
Net Property, Plant & Equipment5.344.915.255.834.693.693.873.653.09
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets1.501.320.660.600.600.660.600.580.65
Deferred Tax Assets3.263.172.802.221.541.050.760.630.36
Other Assets0.010.020.000.000.000.000.004E-050.00
Total Assets67.4954.5152.8846.4541.3637.1133.2429.4027.39
Short Term Debt Incl. Current Port. of LT Debt0.070.200.080.080.000.030.070.031.10
Accounts Payable2.642.671.011.371.260.690.560.590.81
Income Tax Payable-0.000.280.340.050.290.000.290.40
Other Current Liabilities9.517.606.316.265.843.632.362.752.49
Total Current Liabilities12.2210.477.688.057.154.642.993.654.80
Long Term Debt0.060.000.010.080.040.050.010.010.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities1.220.710.650.64-----
Other Liabilities0.000.120.010.010.000.000.000.000.00
Total Liabilities13.5111.308.348.787.194.693.003.674.80
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity53.9843.2144.5537.6734.1732.4230.2525.7322.59
Total Shareholders Equity53.9843.2144.5537.6734.1732.4230.2525.7322.59
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity53.9843.2144.5537.6734.1732.4230.2525.7322.59
Total Liabilities & Stockholders Equity67.4954.5152.8846.4541.3637.1133.2429.4027.39
Book Value Per Share6.455.185.164.404.033.803.533.062.73
Tangible Book Value Per Share6.275.025.084.333.963.723.462.992.65
Full-Time Employees197180174170156132120119132
Price to Book Ratio4.214.263.062.432.392.974.361.872.19
Return on Assets18.5314.0410.377.215.876.7113.306.977.26
Return on Equity23.2617.1812.538.816.927.5414.878.208.79
Return on Invested Capital20.9117.4411.568.396.747.2713.757.698.11
Quick Ratio4.393.995.274.174.396.388.356.004.33
Current Ratio4.694.315.754.694.836.839.386.724.85

Cash flow, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income11.9311.307.545.153.172.312.364.161.98
Depreciation1.081.081.170.840.610.630.610.740.93
Other Funds (Non Cash)2.702.723.271.690.710.981.020.900.94
Funds from Operations16.1315.5311.677.114.443.423.705.683.58
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-6.26-5.86-0.281.96-3.13-4.11-0.62-1.48-0.99
Income Taxes Payable--0.76-0.69-0.060.28-0.240.29-0.29-0.11
Cash from Operating Activities9.879.6611.399.071.31-0.693.084.202.59
Capital Expenditures-1.24-1.30-0.31-0.40-1.72-1.52-0.45-0.98-1.39
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-1.24-1.30-0.31-0.40-1.72-1.52-0.45-0.98-1.39
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-6.39-2.95-9.600.04-0.07-1.45-1.080.080.25
Repurchase of Common Pref Stock-7.24-3.92-10.00-0.28-0.15-1.45-1.120.000.00
Sale of Common Pref Stock0.860.960.400.310.080.000.050.080.25
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.00-1.10
Change in Long Term Debt0.000.000.000.000.000.000.000.00-1.10
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.00-1.10
Net Financing Active Other Cash Flow-0.49-0.25-2.280.00-0.31-0.08-0.14-0.630.00
Other Financing Activities Uses-0.49-0.25-2.280.00-0.31-0.08-0.14-0.630.00
Cash from Financing Activities-6.87-3.20-11.880.04-0.38-1.52-1.22-0.55-0.85
Net Change in Cash1.765.16-0.798.71-0.78-3.741.412.670.35
Free Cash Flow8.708.4111.138.78-0.33-2.112.793.351.26
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow28.4243.6917.6115.17--36.0640.5237.36
Deferred Taxes & Investment Tax Credit-0.43-0.31-0.57-0.04-0.49-0.29-0.13-0.27

Balance sheet, quarterly

Currency USD, millions
Metric2027Q12026Q42026Q32026Q22026Q12025Q4
Cash & Short Term Investments15.8820.4516.9813.7914.1115.29
Short Term Receivables31.7032.0729.3527.4126.1326.10
Inventories3.813.683.293.463.773.30
Other Current Assets0.811.170.600.910.540.39
Total Current Assets52.1957.3750.2345.5744.5645.08
Net Property, Plant & Equipment5.285.345.365.385.164.91
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets1.571.501.421.481.421.32
Deferred Tax Assets2.043.262.462.462.463.17
Other Assets0.010.010.010.020.020.02
Total Assets61.0967.4959.4754.9153.6154.51
Short Term Debt Incl. Current Port. of LT Debt0.000.070.000.000.000.20
Accounts Payable2.352.642.602.323.142.67
Income Tax Payable---0.38-0.00
Other Current Liabilities4.919.517.636.675.627.60
Total Current Liabilities7.2612.2210.239.388.7610.47
Long Term Debt0.000.060.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities-1.22---0.71
Other Liabilities1.360.000.080.100.110.12
Total Liabilities8.6213.5110.319.478.8711.30
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity52.4753.9849.1745.4444.7443.21
Total Shareholders Equity52.4753.9849.1745.4444.7443.21
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity52.4753.9849.1745.4444.7443.21
Total Liabilities & Stockholders Equity61.0967.4959.4754.9153.6154.51
Book Value Per Share6.376.455.945.495.355.18
Tangible Book Value Per Share6.186.275.775.315.185.02
Full-Time Employees-197---180
Price to Book Ratio4.216.563.945.444.744.26
Return on Assets20.7918.5318.0516.7815.9914.04
Return on Equity24.5323.2621.7020.2019.0217.18
Return on Invested Capital5.266.296.116.084.775.10
Quick Ratio6.664.394.594.494.663.99
Current Ratio7.194.694.914.865.094.31

Cash flow, quarterly

Currency USD, millions
Metric2027Q12026Q42026Q32026Q22026Q12025Q4
Net Income2.763.403.002.762.142.20
Depreciation0.270.270.290.260.260.40
Other Funds (Non Cash)0.430.760.850.660.460.86
Funds from Operations3.464.864.143.672.853.15
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-3.09-1.87-0.66-0.65-2.680.71
Cash from Operating Activities0.372.993.483.030.173.86
Capital Expenditures-0.20-0.22-0.15-0.66-0.27-0.16
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.20-0.22-0.15-0.66-0.27-0.16
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-4.280.70-0.12-2.69-0.85-3.65
Repurchase of Common Pref Stock-4.330.00-0.15-2.76-1.00-3.67
Sale of Common Pref Stock0.050.700.040.080.160.02
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.47-0.00-0.01-0.01-0.230.00
Other Financing Activities Uses-0.47-0.00-0.01-0.01-0.230.00
Cash from Financing Activities-4.750.69-0.13-2.69-1.08-3.65
Net Change in Cash-4.583.463.19-0.32-1.170.05
Free Cash Flow0.212.773.332.39-0.083.71
Price to Free Cash Flow28.4243.9121.6530.6724.2917.22

Revenue breakdown

Total Electromedical & Electrotherapeutic Apparatus revenue2025: 64.00M 2026: 73.78M
United States2025: 64.00M 2026: 73.78M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.63%0.2M6.9M83.77K
2026-10-152.83%0.2M6.9M94.57K
2026-09-302.97%0.2M6.9M107.87K
2026-09-152.98%0.2M6.9M107.09K
2026-08-312.64%0.2M6.9M98.83K
2026-08-142.79%0.2M6.9M91.31K
2026-07-312.57%0.2M6.9M93.14K
2026-07-152.84%0.2M6.9M80.98K
2026-06-302.57%0.2M6.9M62.31K
2026-06-152.44%0.2M6.9M55.00K
2026-05-292.29%0.2M6.9M54.23K
2026-05-152.03%0.1M6.9M54.23K
2026-04-302.65%0.2M6.9M63.09K
2026-04-152.36%0.2M6.9M65.48K
2026-03-312.78%0.2M6.9M66.70K
2026-03-132.48%0.2M6.9M67.98K
2026-02-272.59%0.2M6.9M66.76K
2026-02-132.32%0.2M6.9M64.92K
2026-01-302.52%0.2M6.9M49.65K
2026-01-152.82%0.2M6.9M48.53K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call12.5011.1014.600.005.5850.000.000.903-0.1920.007
call15.008.6012.3017.004.7141.000.000.877-0.1820.008
call17.506.109.600.003.5570.000.000.843-0.1690.010
call20.003.407.2026.002.8242.000.000.796-0.1520.011
call22.501.204.906.252.1992.000.000.696-0.1840.014
call25.000.003.702.402.20822.000.000.590-0.1900.015
call30.000.000.500.801.56526.000.000.281-0.1180.013
call35.000.001.150.382.2459.000.000.220-0.1460.012
call40.000.001.050.032.78612.000.000.192-0.1660.011
call45.000.000.353.132.29312.000.000.092-0.0860.007
call50.000.001.055.022.6123.000.000.084-0.0910.006
call55.000.000.253.503.5052.000.000.174-0.2050.011
call60.000.002.150.852.9323.000.000.057-0.0760.005
call65.000.000.100.554.0133.000.000.160-0.2220.011
put12.500.002.150.005.5550.000.00-0.108-0.2260.007
put15.000.002.151.103.6162.000.00-0.108-0.1500.008
put17.500.002.150.302.8391.000.00-0.138-0.1390.009
put20.000.001.300.403.1122.000.00-0.230-0.2100.012
put22.500.002.200.452.20742.000.00-0.322-0.1710.014
put25.000.003.100.952.11011.000.00-0.417-0.1770.015
put30.002.606.603.202.26817.000.00-0.717-0.1130.013
put35.007.4011.507.782.9284.000.00-0.778-0.1430.012
put40.0012.4016.5012.303.4872.000.00-0.807-0.1610.011
put45.0017.4021.500.003.9440.000.00-0.909-0.0830.006
put50.0022.4026.500.004.3320.000.00-0.917-0.0880.006
put55.0027.4031.500.004.6680.000.00-0.939-0.0700.005
put60.0032.6036.500.004.9650.000.00-0.942-0.0720.005
put65.0037.6041.500.005.2300.000.00-0.973-0.0320.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-108-KCurrent report2026-11-10SEC
2026-09-29DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-11-13SEC
2026-09-29DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-09-29ARSAnnual report to security holders. 2026-06-30SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-08-258-KCurrent report2026-08-25SEC
2026-08-2510-KAnnual report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-06-094Statement of changes in beneficial ownership of securities2026-06-08SEC
2026-06-08144Filing for proposed sale of securities under Rule 144.SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-04144Filing for proposed sale of securities under Rule 144.SEC
2026-05-29SDSpecialized Disclosure ReportSEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-15144Filing for proposed sale of securities under Rule 144.SEC
2026-05-1210-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-128-KCurrent report2026-05-12SEC
2026-04-01UPLOADUpload SubmissionSEC
2026-03-26SCHEDULE 13G/ASEC
2026-03-25CORRESPSEC
2026-03-16UPLOADUpload SubmissionSEC
2026-02-108-KCurrent report2026-02-10SEC
2026-02-1010-QQuarterly report pursuant to Section 13 or 15(d)2025-12-31SEC
2025-12-188-KCurrent report2025-12-16SEC
2025-12-034Statement of changes in beneficial ownership of securities2025-12-01SEC
2025-12-034Statement of changes in beneficial ownership of securities2025-12-01SEC
2025-12-034Statement of changes in beneficial ownership of securities2025-12-01SEC
2025-12-034Statement of changes in beneficial ownership of securities2025-12-01SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-0600783.03K2
2026-05001.42M1
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
J.E. Simmons & Co., P.C.5.84%
BlackRock, Inc.5.62%
VANGUARD CAPITAL MANAGEMENT LLC3.42%
GEODE CAPITAL MANAGEMENT, LLC3.22%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.2.64%
ACADIAN ASSET MANAGEMENT LLC2.19%
DIMENSIONAL FUND ADVISORS LP2.17%
TWO SIGMA INVESTMENTS, LP2.02%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC1.88%
GAMCO INVESTORS, INC. ET AL1.71%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.38%
iShares Russell 2000 ETF2.06%
1290 VT GAMCO Small Company Value Portfolio1.71%
VANGUARD EXTENDED MARKET INDEX FUND0.96%
Fidelity Small Cap Index Fund0.88%
iShares Russell 2000 Growth ETF0.76%
U.S. SMALL CAP PORTFOLIO0.56%
Invesco Dorsey Wright SmallCap Momentum ETF0.55%
Ultra-Small Company Fund0.49%
SMALL COMPANY GROWTH PORTFOLIO0.46%

OakChart. ELMD. Cached 15 minutes.